# Ventas Moat

Status: published. Policy: company-analysis-1.

The supplied disclosures support no established durable moat: Ventas explicitly reports limited development barriers, particularly in senior housing, which supplied 58.2% of first-half 2026 NOI. Scale, hospital-linked locations and analytics provide operating capabilities, but demonstrated competitive protection is absent. This does not imply weak current operations: 2025 RevPOR increased 4.7%, occupancy improved and cash generation grew. Pricing strength is demonstrated for that period, while its durability through new supply remains unproven.

## intangible_assets

Existing hospital-linked outpatient locations provide potential location and relationship advantages: 96% of the outpatient medical portfolio was affiliated with health systems or hospitals. The passages do not demonstrate exclusivity, tenant switching costs or sustained rent premiums.

Durability: Physical locations can persist, but affiliation alone does not establish protected demand or durable pricing power.

Risks: Hospital competitiveness, funding pressures and restrictions on alternative property uses can weaken the value of these relationships and locations.

Invalidation: The location-advantage thesis would be undermined by affiliated properties losing tenants or accepting weaker renewal terms despite continued hospital affiliation. Exclusive access or sustained superior renewal economics would challenge the present no-moat assessment.

Competitors: Not established
## cost_advantage

Portfolio scale, access to capital and proprietary analytics are potential sources of operating efficiency. Capital raising and operating growth are demonstrated, but a lower cost than competitors or a defensible analytics advantage is not.

Durability: The platform is established, but the passages provide no comparative cost evidence or demonstrated barrier to replication. Industry demand growth benefits other owners as well.

Risks: Limited development barriers permit competing supply; reliance on third-party operators limits direct control. Equity-funded expansion can increase scale without necessarily improving returns per share.

Invalidation: Persistent occupancy or pricing deterioration after competing supply arrives would undermine the platform-advantage thesis. Sustained comparative cost savings and superior returns through a supply cycle would challenge the present no-moat assessment.

Competitors: Not established
- [https://www.sec.gov/Archives/edgar/data/740260/000074026026000006/vtr-20251231.htm](https://www.sec.gov/Archives/edgar/data/740260/000074026026000006/vtr-20251231.htm) · 2026-02-06
- [https://www.sec.gov/Archives/edgar/data/740260/000074026026000024/vtr-20260630.htm](https://www.sec.gov/Archives/edgar/data/740260/000074026026000024/vtr-20260630.htm) · 2026-07-30
- [https://www.sec.gov/Archives/edgar/data/740260/000074026026000010/vtr-20260401.htm](https://www.sec.gov/Archives/edgar/data/740260/000074026026000010/vtr-20260401.htm) · 2026-04-01
- [https://www.sec.gov/Archives/edgar/data/740260/000074026025000052/vtr-20241231.htm](https://www.sec.gov/Archives/edgar/data/740260/000074026025000052/vtr-20241231.htm) · 2025-02-13
- [https://www.sec.gov/Archives/edgar/data/740260/000074026024000067/vtr-20231231.htm](https://www.sec.gov/Archives/edgar/data/740260/000074026024000067/vtr-20231231.htm) · 2024-02-15
- [https://www.sec.gov/Archives/edgar/data/740260/000074026026000018/vtr-20260331.htm](https://www.sec.gov/Archives/edgar/data/740260/000074026026000018/vtr-20260331.htm) · 2026-04-28

[JSON](https://beanvest.com/stock/vtr/moat.json)